Cancer Screening Has Provided Significant Value to U.S. Population
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 22, 2023 -- Cancer screening has provided significant value to the U.S. population, and improved adherence would add more value, according to a study published online Aug. 7 in BMC Health Services Research.
Tomas J. Philipson, Ph.D., from the University of Chicago, and colleagues built a mathematical model to estimate the aggregate benefits of screenings for breast, colorectal, cervical, and lung cancer over time using U.S. census data. The full potential benefits with perfect adherence and the benefits considering reported adherence were estimated for each screening type.
The researchers found that up to 417 million people were eligible for cancer screening since the initial U.S. Preventive Services Task Force (USPSTF) recommendations. The life-years gained from screenings were estimated to be 15.5 to 21.3 million assuming perfect adherence to recommendations (2.2 to 4.9, 1.4 to 3.6, 11.4 to 12.3, and 0.5 million for breast, colorectal, cervical, and lung cancer, respectively). Combined screening has saved 12.2 to 16.2 million life-years at reported adherence rates since the introduction of the USPSTF recommendations. These benefits represent a value of $8.2 to $11.3 trillion at full potential and $6.5 to $8.6 trillion at current adherence levels. With perfect adherence, single-site screenings could save an additional 3.2 to 5.1 million life-years, representing $1.7 to $2.7 trillion.
"Single-site cancer screenings have offered significant cumulative gains to U.S. life-years gained and improvements to value of screening, despite screening adherence leading to a nontrivial gap between full potential and realized benefit considering adherence," the authors write.
Several authors disclosed ties to Grail LLC, which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Pandemic Had Temporary Negative Effect on Breast Cancer Screening
THURSDAY, May 30, 2024 -- The COVID-19 pandemic had a transient negative effect on breast cancer screening overall and a prolonged negative effect on follow-up screening...
Patient Characteristics Linked to Performance of AI Algorithm for DBT
THURSDAY, May 30, 2024 -- For analyzing negative screening digital breast tomosynthesis (DBT) examinations, patient characteristics influence the case and risk scores of an...
Recommendations Issued for Palliative RT for Symptomatic Bone Mets
THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.